Clinical Trials · NCT01750398
Bipolar Androgen-based Therapy for Prostate Cancer (BAT)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Enrollment
- 33
- Start date
- Jan 2013
- Locations
- 1 site, United States
- Primary endpoint
- Patients With PSA <4 ng/mL at the End of the Study